We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$714M
AUM Growth
+$23.4M
Cap. Flow
+$11.1M
Cap. Flow %
1.56%
Top 10 Hldgs %
29.89%
Holding
173
New
5
Increased
45
Reduced
47
Closed
5

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.26M
2
TRIP icon
TripAdvisor
TRIP
+$2.13M
3
NVS icon
Novartis
NVS
+$2M
4
BC icon
Brunswick
BC
+$1.43M
5
DEO icon
Diageo
DEO
+$1.25M

Top Sells

Rank Stock Value
1
SEE
Sealed Air
SEE
+$1.73M
2
AMGN icon
Amgen
AMGN
+$1.13M
3
HRL icon
Hormel Foods
HRL
+$1.01M
4
COP icon
ConocoPhillips
COP
+$703K
5
EQNR icon
Equinor
EQNR
+$514K

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Healthcare 19.34%
3 Consumer Staples 12.3%
4 Industrials 10.11%
5 Energy 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
126
GSK
GSK
$108B
$406K 0.06%
7,498
-640
-8% -$33.7K
CSCO icon
127
Cisco
CSCO
$456B
$402K 0.06%
14,002
– –
META icon
128
Meta Platforms (Facebook)
META
$1.51T
$400K 0.06%
3,502
+725
+26% +$83.5K
NVO
129
Novo Nordisk
NVO
$225B
$396K 0.06%
14,734
-720
-5% -$19.7K
EV
130
DELISTED
Eaton Vance Corp.
EV
$392K 0.05%
11,082
– –
V icon
131
Visa
V
$697B
$390K 0.05%
5,262
-30
-0.6% -$2.35K
BMRN icon
132
BioMarin Pharmaceuticals
BMRN
$12B
$377K 0.05%
4,847
+188
+4% +$16K
BIIB icon
133
Biogen
BIIB
$30.4B
$374K 0.05%
1,547
– –
TGT icon
134
Target
TGT
$65.5B
$373K 0.05%
5,336
– –
HUBB icon
135
Hubbell
HUBB
$25.6B
$364K 0.05%
3,455
– –
POPE
136
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$353K 0.05%
5,500
– –
GPC icon
137
Genuine Parts
GPC
$17.9B
$340K 0.05%
3,362
– –
KDP icon
138
Keurig Dr Pepper
KDP
$42.3B
$335K 0.05%
3,469
– –
BA icon
139
Boeing
BA
$175B
$330K 0.05%
2,543
– –
K
140
DELISTED
Kellanova
K
$329K 0.05%
4,292
– –
CSX icon
141
CSX Corp
CSX
$94.2B
$327K 0.05%
37,632
-1,800
-5% -$15.7K
EPD icon
142
Enterprise Products Partners
EPD
$83.6B
$326K 0.05%
11,136
-120
-1% -$3.22K
WFM
143
DELISTED
Whole Foods Market Inc
WFM
$326K 0.05%
10,193
– –
SGEN
144
DELISTED
Seagen Inc. Common Stock
SGEN
$323K 0.05%
8,001
+413
+5% +$15.7K
ORCL icon
145
Oracle
ORCL
$346B
$319K 0.04%
7,786
-1,096
-12% -$43.8K
CELG
146
DELISTED
Celgene Corp
CELG
$314K 0.04%
3,185
– –
STR
147
DELISTED
QUESTAR CORP
STR
$313K 0.04%
12,343
– –
BCR
148
DELISTED
CR Bard Inc.
BCR
$308K 0.04%
1,311
– –
ALXN
149
DELISTED
Alexion Pharmaceuticals
ALXN
$305K 0.04%
2,613
+114
+5% +$16.2K
ESRX
150
DELISTED
Express Scripts Holding Company
ESRX
$293K 0.04%
3,870
– –
3 4 5
6
7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q2 2016 Portfolio in Review

As of Q2 2016, Grandfield & Dodd held 173 positions worth $714M, up 3.4% from $691M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q2 2016 filing shows 5 new, 45 increased, 47 reduced and 5 closed positions. Its largest new stake was Sanofi: 79,385 shares worth $3.32M. The largest sale was Sealed Air, an estimated $1.73M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grandfield & Dodd's largest Q2 2016 buy was Sanofi: 79,385 shares worth $3.32M.
  • Grandfield & Dodd added most to Novartis in Q2 2016, an estimated $2M increase.
  • Grandfield & Dodd's biggest Q2 2016 reduction was Sealed Air, cutting an estimated $1.73M.
  • Grandfield & Dodd fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $331K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $714M portfolio in Q2 2016.
  • Grandfield & Dodd opened 5 new positions and closed 5 in Q2 2016.
  • Grandfield & Dodd's portfolio value rose 3.4% quarter-over-quarter to $714M.

Based on Grandfield & Dodd's 13F filing for Q2 2016, filed 28 Jul 2016.